Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
3(23%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
12
92%
Ph phase_3
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
12(92.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(9)
Terminated(1)

Detailed Status

Completed9
Recruiting3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (7.7%)
N/A12 (92.3%)

Trials by Status

completed969%
recruiting323%
withdrawn18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DEVICE
Total Trials
13